Strongyloides stercoralis in an immunocompetent adult: An unexpected cause of weight lost


Strongyloides stercoralis infects at least 100 million humans worldwide each year, but its prevalence is underestimated. It is endemic in hot and humid climates as well as resource poor countries with inadequate sanitary conditions. The rise of international travel and immigration has a positive impact in strongyloidiasis. Due to its unique auto infection life-cycle, Strongyloides may lead to chronic infections remaining undetected for decades. Strongyloidiasis is most often asymptomatic but it has a wide range of clinical presentations. The two most severe forms of strongyloidiasis are hyperinfection and disseminated syndromes. These occur most often in patients with impaired cell mediated immunity. A 42-year-old immunocompetent man presented with chronic watery diarrhea, malaise, upper abdominal pain, anorexia and weight lost. Strongyloides stercoralis was identified in stool samples and duodenal biopsy. The patient was successfully treated with albendazole. The authors report a case of strongyloidiasis hyperinfection in an immunocompetent host 20 years away from an endemic area and make a literature review.

Share and Cite:

Marques, L. , Rodrigues, A. , Vedes, E. and Marques, D. (2013) Strongyloides stercoralis in an immunocompetent adult: An unexpected cause of weight lost. Case Reports in Clinical Medicine, 2, 427-431. doi: 10.4236/crcm.2013.27112.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Tiwari, S., Rautaraya, B. and Tripathy, K.P. (2012) Hyperinfection of Strongyloides stercoralis in an immunocompetent patient. Tropical Parasitology, 2, 135-137.
[2] Genta, R.M. (1989) Global prevalence of strongyloidiasis: Critical review with epidemiologic insights into the prevention of disseminated disease. Reviews of Infectious Diseases, 11, 755-767.
[3] Gill, G.V., Welch, E., Bailey, J.W., Bell, D.R. and Beeching, N.J. (2004) Chronic Strongyloides stercoralis infection in former British Far East prisoners of war. QJM, 97, 789-795.
[4] Valerioa, L., Rourea, S., Fernández-Rivasb, G., Basilec, L., Martínez-Cuevasa, O., Ballesterosd, Á.-L., et al. (2013) Strongyloides stercoralis, the hidden worm. Epidemiological and clinical characteristics of 70 cases diagnosed in the North Metropolitan Area of Barcelona, Spain, 2003-2012. Transactions of the Royal Society of Tropical Medicine and Hygiene, 107, 465-470.
[5] Kassalik, M. and Mönkemüller, K. (2011) Strongyloides stercoralis hyperinfection syndrome and disseminated disease. Gastroenterology & Hepatology, 7, 766-768.
[6] CDC, DPDx (2009) Parasites and health: Strongyloidiasis. Centers for Disease Control & Prevention.
[7] Grove, D.I. (1996) Human strongyloidiasis. Advances in Parasitology, 38, 251-309.
[8] Jorgensen, T., Montresor, A. and Savioli, L. (1996) Effectively controlling strongyloidiasis. Parasitology Today, 12, 164.
[9] Bisoffi, Z., Buonfrate, D., Montresor, A., Requena-Méndez, A., Muños, J., Krolewiecki, A.J., et al. (2013) Strongyloides stercoralis: A plea for action. PLOS Neglected Tropical Diseases, 7, Article ID: e2214.
[10] Montes, M., Sawhney, C. and Barros, N. (2010) Strongyloides stercoralis: There but not seen. Current Opinion in Infectious Diseases, 23, 500-504.
[11] Liu, L.X. and Weller, P.F. (1993) Strongyloidiasis and other intestinal nematode infections. Infectious Disease Clinics of North America, 7, 655-682.
[12] Roxby, A.C., Gottlieb, G.S. and Limaye, A.P. (2009) Strongyloidiasis in transplant patients. Clinical Infectious Diseases, 49, 1411-1423.
[13] Thompson, B.F., Fry, L.C., Wells, C.D., et al. (2004) The spectrum of GI strongyloidiasis: An endoscopic-pathologic study. Gastrointestinal Endoscopy, 59, 906-910.
[14] Marcos, L.A., Terashima, A., Dupont, H.L. and Gotuzzo, E. (2008) Strongyloides hyperinfection syndrome: An emerging global infectious disease. Transactions of the Royal Society of Tropical Medicine and Hygiene, 102, 314-318.
[15] Vigg, A., Mantri, S., Reddy, V.A. and Biyani, V. (2006) Acute respiratory distress syndrome due to Strongyloides stercoralis in non-Hodgkin’s lymphoma. Indian Journal of Chest Disease and Allied Science, 48, 67-69.
[16] Azira, N.M. and Zeehaida, M. (2010) Strongyloides stercoralis hyperinfection in a diabetic patient: Case report. Tropical Biomedicine, 27, 115-119.
[17] Murali, A., Rajendiran, G., Ranganathan, K. and Shanthakumari, S. (2010) Disseminated infection with Strongyloides stercoralis in a diabetic patient. Indian Journal of Medical Microbiology, 28, 407-408.
[18] Ganesh, S. and Cruz Jr., R.J. (2011) Strongyloidiasis: A multifaceted disease. Journal of Gastroenterology and Hepatology, 7, 194-196.
[19] Gill, G.V. and Bell, D.R. (1979) Strongyloides stercoralis infection in former far east prisoners of war. British Medical Journal, 2, 572-574.
[20] Neumann, I., Ritter, R. and Mounsey, A. (2012) Strongyloides as a cause of fever of unknown origin. JABFM, 25, 390-393.
[21] Siddiqui, A.A. and Berk, S.L. (2001) Diagnosis of Strongyloides stercoralis infection. Clinical Infectious Diseases, 33, 1040-1047.
[22] Segarra-Newnham, M. (2007) Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection. Annals of Pharmacotherapy, 41, 1992-2001.
[23] Dreyer, G., Fernandes-Silva, E., Alves, S., Rocha, A., Albuquerque, R., et al. (1996) Patterns of detection of Strongyloides stercoralis in stool specimens: Implications for diagnosis and clinical trials. Journal of Clinical Microbiology, 34, 2569-2571.
[24] Kishimoto, K., Hokama, A., Hirata, T., Ihama, Y., Nakamoto, M., Kinjo, N., et al. (2008) Endoscopic and histopathological study on the duodenum of Strongyloides stercoralis hyperinfection. World Journal of Gastroenterology, 4, 1768-1773.
[25] Krolewiecki, A.J., Ramanathan, R., Fink, V., McAuliffe, I., Cajal, S.P., et al. (2010) Improved diagnosis of Strongyloides stercoralis using recombinant antigen-based serologies in a community-wide study in northern Argentina. Clinical and Vaccine Immunology, 17, 1624-1630.
[26] Requena-Méndez, A., Chiodini, P., Bisoffi, Z., Buonfrate, D., Gotuzzo, E., et al. (2013) The laboratory diagnosis and follow up of strongyloidiasis: A systematic review. PLOS Neglected Tropical Diseases, 7, Article ID: e2002.
[27] Pitisuttithum, P., Supanaranond, W. and Chindanond, D. (1995) A randomized comparative study of albendazole and thiabendazole in chronic Strongyloidiasis. The Southeast Asian Journal of Tropical Medicine and Public Health, 26, 735-738.
[28] WHO (2008) WHO model formulary.
[29] Marti, H., Haji, H.J., Savioli, L., Chwaya, H.M., Mgeni, A.F., et al. (1996) A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. The American Journal of Tropical Medicine and Hygiene, 55, 477-481.
[30] Romero-Cabello, R., Villagroy Gómez, J., Hermández González, M. and Romero Feregrino, R. (2012) Hyperinfection with Strongyloides stercoralis. BMJ Case Reports, 785-786.
[31] Keiser, P.B. and Nutman, T.B. (2004) Strongyloides stercoralis in the immunocompromised population. Clinical Microbiology Reviews, 17, 208-217.
[32] Krolewiecki, A.J., Lammie, P., Jacobson, J., Gabrielli, A.-F., Levecke, B., Socias, E., et al. (2013) A public health response against Strongyloides stercoralis: Time to look at soil-transmitted helminthiasis in full. PLOS Neglected Tropical Diseases, 7, Article ID: e2165.
[33] Becker, S.L., Sieto, B., Silue, K.D., Adjossan, L., Kone, S., et al. (2012) Diagnosis, clinical features, and self-reported morbidity of Strongyloides stercoralis and hookworm infection in a Co-endemic setting. PLOS Neglected Tropical Diseases, 5, Article ID: e1292.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.